Current strategies in the treatment of metastatic hormone-refractory prostate cancer.
Ghosn
Marwan
M
Hematology-Oncology Department, Hôtel-Dieu de France University Hospital, Beirut, Lebanon.
Kattan
Joseph
J
Younes
Fariha
F
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D010166:Palliative Care / Q000379:methods*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal